- Home
- SLNO vs TGLS Comparison
SLNO vs TGLS Comparison
Compare SLNO & TGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- TGLS
- Stock Information
- Founded
- SLNO 1999
- TGLS 1984
- Country
- SLNO United States
- TGLS Colombia
- Employees
- SLNO N/A
- TGLS N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TGLS Electronic Components
- Sector
- SLNO Health Care
- TGLS Consumer Discretionary
- Exchange
- SLNO Nasdaq
- TGLS Nasdaq
- Market Cap
- SLNO 3.8B
- TGLS 4.0B
- IPO Year
- SLNO 2014
- TGLS 2012
- Fundamental
- Price
- SLNO $86.00
- TGLS $75.55
- Analyst Decision
- SLNO Strong Buy
- TGLS Buy
- Analyst Count
- SLNO 9
- TGLS 4
- Target Price
- SLNO $105.11
- TGLS $77.25
- AVG Volume (30 Days)
- SLNO 1.5M
- TGLS 276.6K
- Earning Date
- SLNO 08-06-2025
- TGLS 08-07-2025
- Dividend Yield
- SLNO N/A
- TGLS 0.77%
- EPS Growth
- SLNO N/A
- TGLS 6.50
- EPS
- SLNO N/A
- TGLS 3.70
- Revenue
- SLNO N/A
- TGLS $919,842,000.00
- Revenue This Year
- SLNO N/A
- TGLS $14.13
- Revenue Next Year
- SLNO $506.77
- TGLS $11.12
- P/E Ratio
- SLNO N/A
- TGLS $20.42
- Revenue Growth
- SLNO N/A
- TGLS 11.73
- 52 Week Low
- SLNO $41.50
- TGLS $46.47
- 52 Week High
- SLNO $90.32
- TGLS $90.34
- Technical
- Relative Strength Index (RSI)
- SLNO 54.38
- TGLS 45.23
- Support Level
- SLNO $83.53
- TGLS $75.97
- Resistance Level
- SLNO $89.12
- TGLS $78.28
- Average True Range (ATR)
- SLNO 2.65
- TGLS 1.89
- MACD
- SLNO -0.34
- TGLS 0.27
- Stochastic Oscillator
- SLNO 56.91
- TGLS 39.09
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About TGLS Tecnoglass Inc.
Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.